Skip to main content

Animations

MJFF Publications

3176 - 3200 of 6570 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2020
  • Summary Details
    OPEN
    Title: In situ architecture of the lipid transport protein VPS13C at ER–lysosome membrane contacts
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2203769119
    Citation Count: 90
  • Summary Details
    OPEN
    Title: WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2022.892899
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts
    Journal Name: Journal of Personalized Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jpm12060921
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12353
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00371-7
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00375-3
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac177
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00360-5
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches
    Journal Name: Journal of Personalized Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jpm12071057
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01399-4
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00643-4
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Structure of the second phosphoubiquitin–binding site in parkin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Height and nigral neuron density in Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02775-2
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-022-00309-x
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.886575
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03610-7
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac155
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Disruption of mitochondrial complex I induces progressive parkinsonism
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-04059-0
    Citation Count: 556
  • Summary Details
    OPEN
    Title: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.889647
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11221-9
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2022.104476
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Recent Advances on Graph Analytics and Its Applications in Healthcare
    Journal Name: Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining
    Publisher: ACM
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1145/3394486.3406469
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.